Gilead Sciences Com (GILD) Shareholder Stonebridge Capital Management Upped Position by $938,520 as Share Value Rose; As Honeywell International (HON) Stock Value Declined, West Oak Capital Cut by $5.52 Million Its Holding

May 22, 2018 - By Dolores Ford

Honeywell International Inc. (NYSE:HON) Logo

Stonebridge Capital Management Inc increased its stake in Gilead Sciences Inc Com (GILD) by 28.42% based on its latest 2017Q4 regulatory filing with the SEC. Stonebridge Capital Management Inc bought 11,880 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 53,675 shares of the health care company at the end of 2017Q4, valued at $4.24 million, up from 41,795 at the end of the previous reported quarter. Stonebridge Capital Management Inc who had been investing in Gilead Sciences Inc Com for a number of months, seems to be bullish on the $88.70 billion market cap company. The stock increased 0.86% or $0.58 during the last trading session, reaching $68.21. About 3.30 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 22, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

West Oak Capital Llc decreased its stake in Honeywell International (HON) by 1.05% based on its latest 2017Q4 regulatory filing with the SEC. West Oak Capital Llc sold 36 shares as the company’s stock declined 5.96% with the market. The institutional investor held 3,386 shares of the o.e.m. company at the end of 2017Q4, valued at $519.28M, down from 3,422 at the end of the previous reported quarter. West Oak Capital Llc who had been investing in Honeywell International for a number of months, seems to be less bullish one the $113.23 billion market cap company. The stock increased 0.73% or $1.1 during the last trading session, reaching $151.59. About 1.51 million shares traded. Honeywell International Inc. (NYSE:HON) has risen 15.94% since May 22, 2017 and is uptrending. It has outperformed by 4.39% the S&P500.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Kite Pharma continues buildout for cell therapy manufacture” on May 15, 2018, also Seekingalpha.com with their article: “Gilead Sciences: Resist Sentiment, Stop Speculating And Invest” published on May 15, 2018, Seekingalpha.com published: “Gilead: Where’s The Next Catalyst?” on May 18, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: I’m Thankful That I Sold” published on May 07, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead: What A Disaster” with publication date: May 08, 2018.

Since January 2, 2018, it had 0 insider buys, and 22 sales for $44.80 million activity. On Monday, March 12 Cogan John Francis sold $472,065 worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 5,833 shares. MARTIN JOHN C sold 50,000 shares worth $3.66 million. $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by Washington Robin L. 100,000 shares were sold by Meyers James R, worth $8.02 million on Tuesday, January 16. WILSON GAYLE E also sold $4.68M worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, February 9.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Jpmorgan Chase And Company has invested 0.18% in Gilead Sciences, Inc. (NASDAQ:GILD). Suntrust Banks owns 142,479 shares. Abner Herrman Brock Limited Liability accumulated 9,636 shares. United Automobile Association owns 1.42 million shares. Moreover, Rmb Mngmt Lc has 0.09% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Pinnacle Limited stated it has 0.4% in Gilead Sciences, Inc. (NASDAQ:GILD). Moreover, Hanseatic Mngmt Services has 0.04% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Logan Capital Mgmt invested 0.02% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Wesbanco Bancorporation reported 0.13% in Gilead Sciences, Inc. (NASDAQ:GILD). Buckingham Asset Management Ltd Liability invested in 4,799 shares. Arizona State Retirement Sys holds 0.23% or 330,962 shares. Masters Cap Limited Liability Corporation reported 0.51% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 413,285 are held by Sei Investments. Natixis has 0.17% invested in Gilead Sciences, Inc. (NASDAQ:GILD). 32,847 were reported by Cetera Advisor Limited Liability Corporation.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. Mizuho maintained the stock with “Buy” rating in Tuesday, July 25 report. The company was maintained on Wednesday, February 3 by Piper Jaffray. The firm earned “Buy” rating on Wednesday, July 29 by Maxim Group. The stock has “Outperform” rating by Leerink Swann on Friday, February 5. On Wednesday, February 3 the stock rating was maintained by Credit Suisse with “Outperform”. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, October 3 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Equal-Weight” rating given on Friday, October 6 by Morgan Stanley. The firm has “Neutral” rating given on Wednesday, February 7 by Bank of America. As per Thursday, September 10, the company rating was upgraded by Jyske Bank. On Wednesday, October 4 the stock rating was maintained by Jefferies with “Hold”.

Stonebridge Capital Management Inc, which manages about $462.82 million and $281.11 million US Long portfolio, decreased its stake in Nestle S A Sponsored Adr (NSRGY) by 4,212 shares to 35,739 shares, valued at $3.04M in 2017Q4, according to the filing. It also reduced its holding in Biogen Idec Inc Com (NASDAQ:BIIB) by 1,738 shares in the quarter, leaving it with 2,736 shares, and cut its stake in Intel Corp (NASDAQ:INTC).

Investors sentiment decreased to 1.11 in 2017 Q4. Its down 0.03, from 1.14 in 2017Q3. It fall, as 42 investors sold HON shares while 490 reduced holdings. 154 funds opened positions while 439 raised stakes. 531.30 million shares or 5.59% less from 562.75 million shares in 2017Q3 were reported. Veritas Inv Ltd Liability Partnership holds 0.01% of its portfolio in Honeywell International Inc. (NYSE:HON) for 525 shares. Segment Wealth Management Ltd Llc accumulated 0.99% or 26,620 shares. Howe Rusling stated it has 0.12% of its portfolio in Honeywell International Inc. (NYSE:HON). Family Firm reported 2,138 shares. Gabelli Funds Limited Liability Corp holds 1.07% or 1.21 million shares. Cv Starr & Trust holds 70,000 shares or 4.71% of its portfolio. Vestor Capital Ltd Limited Liability Company, a Illinois-based fund reported 60,362 shares. Berkshire Asset Limited Liability Co Pa accumulated 133,750 shares or 1.99% of the stock. Columbia Prns L L C Invest Mngmt holds 0.35% or 17,114 shares in its portfolio. Destination Wealth Mngmt holds 3,814 shares or 0.04% of its portfolio. Meridian Investment Counsel reported 0.67% in Honeywell International Inc. (NYSE:HON). Modera Wealth Ltd Liability holds 6,113 shares. D E Shaw And owns 578,034 shares or 0.12% of their US portfolio. Mathes Com accumulated 1,410 shares or 0.1% of the stock. 1.07 million are owned by Thrivent Fin For Lutherans.

More recent Honeywell International Inc. (NYSE:HON) news were published by: Pennenergy.com which released: “Cureton Midstream to use Honeywell connected plant to improve reliability of gas processing” on May 22, 2018. Also Seekingalpha.com published the news titled: “Honeywell’s Free Cash Flow Is Amazing” on April 23, 2018. Seekingalpha.com‘s news article titled: “Trade War Relief Rally – Cramer’s Mad Money (5/21/18)” with publication date: May 22, 2018 was also an interesting one.

West Oak Capital Llc, which manages about $281.18 million and $162.92B US Long portfolio, upped its stake in T Rowe Price Group Inc (NASDAQ:TROW) by 625 shares to 7,135 shares, valued at $748.68M in 2017Q4, according to the filing. It also increased its holding in Corindus Vascular by 4,800 shares in the quarter, for a total of 5,500 shares, and has risen its stake in Avery Dennison Corp (NYSE:AVY).

Analysts await Honeywell International Inc. (NYSE:HON) to report earnings on July, 20. They expect $2.00 earnings per share, up 11.11% or $0.20 from last year’s $1.8 per share. HON’s profit will be $1.49 billion for 18.95 P/E if the $2.00 EPS becomes a reality. After $1.95 actual earnings per share reported by Honeywell International Inc. for the previous quarter, Wall Street now forecasts 2.56% EPS growth.

Honeywell International Inc. (NYSE:HON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: